Lv1
46 积分 2022-06-24 加入
Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications
3个月前
已完结
Sensitive CAR T cells redefine targetable CD70 expression in solid tumors
3个月前
已完结
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
3个月前
已完结
pTα enhances mRNA translation and potentiates CAR T cells for solid tumor eradication
3个月前
已完结
Preclinical development and a phase 1 trial of IMC001, an EpCAM-targeted CAR-T cell therapy, in patients with advanced gastric cancer
3个月前
已完结
Optimizing In Vivo CAR-T Cell Engineering for Cancer Immunotherapy
4个月前
已完结
Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery to T cells and in vivo CAR T-cell engineering
4个月前
已完结
CD4+ T cells mediate CAR-T cell-associated immune-related adverse events after BCMA CAR-T cell therapy
4个月前
已完结
T cell-engaging therapies — BiTEs and beyond
7个月前
已完结
Beyond the blood: expanding CAR T cell therapy to solid tumors
8个月前
已完结
皖公网安备34019202002308
